BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10810378)

  • 1. Radioimmunoscintigraphy and radioimmunotherapy in cancer: principles and application.
    Potamianos S; Varvarigou AD; Archimandritis SC
    Anticancer Res; 2000; 20(2A):925-48. PubMed ID: 10810378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical radioimmunotherapy.
    Knox SJ; Meredith RF
    Semin Radiat Oncol; 2000 Apr; 10(2):73-93. PubMed ID: 10727597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radioimmunoscintigraphy and radioimmunotherapy--approaches towards future aspects].
    Nakamura K
    Kaku Igaku; 1994 Sep; 31(9):1133-40. PubMed ID: 7967199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour imaging with radiolabelled monoclonal antibodies.
    Britton KE
    Wien Klin Wochenschr; 1994; 106(2):35-6. PubMed ID: 8146993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radiolabeled antibodies for cancer treatment].
    Barbet J; Chatal JF; Kraeber-Bodéré F
    Med Sci (Paris); 2009 Dec; 25(12):1039-45. PubMed ID: 20035676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between radioimmunotherapy and external beam radiation therapy for patients with hepatocellular carcinoma.
    Zeng ZC; Tang ZY; Yang BH; Liu KD; Wu ZQ; Fan J; Qin LX; Sun HC; Zhou J; Jiang GL
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1657-68. PubMed ID: 12458401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab' fragments.
    Casey JL; Pedley RB; King DJ; Green AJ; Yarranton GT; Begent RH
    Br J Cancer; 1999 Nov; 81(6):972-80. PubMed ID: 10576653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunodiagnosis and therapy.
    Verhaar-Langereis MJ; Zonnenberg BA; de Klerk JM; Blijham GH
    Cancer Treat Rev; 2000 Feb; 26(1):3-10. PubMed ID: 10660488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematologic side effects of radiolabeled immunoglobulin therapy.
    Vriesendorp HM; Quadri SM; Andersson BS; Dicke KA
    Exp Hematol; 1996 Aug; 24(10):1183-90. PubMed ID: 8765492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The feasibility of radioimmunotherapy of head and neck cancer.
    Gerretsen M; Quak JJ; Brakenhoff RH; Snow GB; van Dongen GA
    Eur J Cancer B Oral Oncol; 1994; 30B(2):82-7. PubMed ID: 8032305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunodetection and therapy of breast cancer.
    DeNardo SJ
    Semin Nucl Med; 2005 Apr; 35(2):143-51. PubMed ID: 15765377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. General overview of radioimmunotherapy of solid tumors.
    Navarro-Teulon I; Lozza C; Pèlegrin A; Vivès E; Pouget JP
    Immunotherapy; 2013 May; 5(5):467-87. PubMed ID: 23638743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunotherapy of cancer: using monoclonal antibodies to target radiotherapy.
    Illidge TM; Brock S
    Curr Pharm Des; 2000 Sep; 6(14):1399-418. PubMed ID: 10903400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-based targeted radiation to pediatric tumors.
    Modak S; Cheung NK
    J Nucl Med; 2005 Jan; 46 Suppl 1():157S-63S. PubMed ID: 15653664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunotherapy of solid cancers: A review.
    Kairemo KJ
    Acta Oncol; 1996; 35(3):343-55. PubMed ID: 8679266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Criteria for the selection of radionuclides for targeting nuclear antigens for cancer radioimmunotherapy.
    Srivastava SC
    Cancer Biother Radiopharm; 1996 Feb; 11(1):43-50. PubMed ID: 10851519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined radioimmunotherapy and chemotherapy of breast tumors with Y-90-labeled anti-Her2 and anti-CEA antibodies with taxol.
    Crow DM; Williams L; Colcher D; Wong JY; Raubitschek A; Shively JE
    Bioconjug Chem; 2005; 16(5):1117-25. PubMed ID: 16173788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunotherapy and colorectal cancer.
    Koppe MJ; Bleichrodt RP; Oyen WJ; Boerman OC
    Br J Surg; 2005 Mar; 92(3):264-76. PubMed ID: 15739250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose radioimmunotherapy combined with extracorporeal depletion in a syngeneic rat tumor model: evaluation of toxicity, therapeutic effect, and tumor model.
    Mårtensson L; Nilsson R; Ohlsson T; Sjögren HO; Strand SE; Tennvall J
    Cancer; 2010 Feb; 116(4 Suppl):1043-52. PubMed ID: 20127949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunotherapy with monoclonal antibodies. A new horizon in nuclear medicine therapy?
    Sautter-Bihl ML; Bihl H
    Nuklearmedizin; 1994 Aug; 33(4):167-73. PubMed ID: 7971292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.